Table 5.
Ref | Core | Shell | Molecular Targeting | Drug/Gene Embedded in the Agent |
---|---|---|---|---|
[86] | air | polymer | NA | quercetin-modified sulfur nanoparticles-loaded bubble |
[88] | C5F12 | polymer | des-octanoyl ghrelin-conjugated bubble | TGFβ1 inhibitor (LY364947)-loaded bubble |
[89] | SF6 | lipid | NA | GDNFp/BDNFp-loaded liposome bound to bubble |
[90] | SF6 | lipid | NA | ultrasound-sensitizing dye-incorporating nanoparticles bound to bubble |
[110] | C3F8 | lipid | NGR-conjugated (targeting)/shBirc5-loaded (gene) liposome bound to bubble | |
[104] | C3F8 | lipid | anti-VEGFR2 antibody-conjugated bubble | pLUC / pHSV-TK/GCV-loaded bubble |
[109] | C3F8 | lipid | NA | SPIO-DOX-conjugated bubble |
[111] | C3F8 | lipid | NA | GDNFp-loaded cationic bubble |
[112] | C3F8 | lipid | NA | pDC315/Nrf2-loaded bubble |
[107] | C3F8 | lipid | folate-conjugated bubble | pLUC-loaded bubble |
[105] | C3F8 | lipid | NA | pPrestin-loaded bubble |
[106] | C3F8 | lipid | NA | boron-containing polyanion nanoparticles coupled with cationic bubble |
[125] | C3F8 | lipid | NA | PSPIO-GDNFp-loaded bubble |
[113] | C3F8 | lipid | phosphatidylserine nanoparticles-microbubble complex |
TGFβ1: transforming growth factor; GDNFp: a glial cell line-derived neurotrophic factor plasmid DNA; BDNFp: brain-derived neurotrophic factor plasmid DNA; NGR: Asn-Gly-Arg peptide; shBirc5: short hairpin RNA-Birc5 gene; VEGFR2: vascular endothelial growth factor receptor 2; pLUC: plasmid DNA encoding luciferase gene; pHSV-TK/GCV: plasmid DNA encoding herpes simplex virus type 1 thymidine kinase/ganciclovir gene; SPIO-DOX: superparamagnetic iron oxide-doxorubicin complex; pDC315/Nrf2: plasmid DNA encoding DC315-nuclear factor E2-related factor 2; pPrestin: plasmid DNA encoding Prestin protein; PSPIO-GDNFp: superparamagnetic iron oxide coated with cationic polyethylenimine conjugated with plasmid DNA encoding glial cell line-derived neurotrophic factor; NA: Not applicable).